dimyristoylphosphatidylcholine has been researched along with Arteriosclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fogelman, AM; Hama, S; Hough, G; Navab, M | 1 |
| Fogelman, AM; Grijalva, V; Hama, S; Hough, G; Navab, M; Nguyen, JT; Reddy, ST | 1 |
| Hakamata, H; Horiuchi, S; Kobori, S; Miyazaki, A; Morikawa, W; Sakai, M; Sakamoto, YI; Schichiri, M; Suginohara, Y | 1 |
| Arnold, K; Dietrich, U; Gawrisch, K; Gutberlet, T; Huster, D; Paasche, G; Zschörnig, O | 1 |
| Dong, LM; Yamamoto, A; Yamamura, T | 1 |
5 other study(ies) available for dimyristoylphosphatidylcholine and Arteriosclerosis
| Article | Year |
|---|---|
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice.
Topics: Administration, Oral; Animals; Apolipoprotein A-I; Apolipoproteins E; Arteriosclerosis; Chemotaxis; Cholesterol, HDL; Coculture Techniques; Dimyristoylphosphatidylcholine; Female; Lipoproteins, HDL; Male; Mice; Mice, Knockout; Monocytes | 2003 |
Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
Topics: Age Factors; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cell Cycle Proteins; Diet, Atherogenic; Dimyristoylphosphatidylcholine; Dual Specificity Phosphatase 1; Enzyme Induction; Immediate-Early Proteins; JNK Mitogen-Activated Protein Kinases; Liver; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; Models, Animal; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 1; Protein Processing, Post-Translational; Protein Tyrosine Phosphatases; Receptors, LDL; RNA, Messenger; Sex Factors; Vanadates | 2004 |
Reconstituted high density lipoprotein reduces the capacity of oxidatively modified low density lipoprotein to accumulate cholesteryl esters in mouse peritoneal macrophages.
Topics: Animals; Apolipoprotein A-I; Arteriosclerosis; Cell-Free System; Chemical Phenomena; Chemistry, Physical; Cholesterol Esters; Chromatography, Gel; Dimyristoylphosphatidylcholine; Endocytosis; Foam Cells; Lipoproteins, LDL; Liposomes; Macrophages, Peritoneal; Male; Membrane Proteins; Mice; Mice, Mutant Strains; Oxidation-Reduction; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B | 1996 |
Investigation of phospholipid area compression induced by calcium-mediated dextran sulfate interaction.
Topics: Arteriosclerosis; Biophysical Phenomena; Biophysics; Calcium; Dextran Sulfate; Dimyristoylphosphatidylcholine; Glycosaminoglycans; Humans; In Vitro Techniques; Lipid Bilayers; Macromolecular Substances; Magnetic Resonance Spectroscopy; Models, Biological; Molecular Weight; Phospholipids; Static Electricity; Surface Tension; X-Ray Diffraction | 1999 |
Enhanced binding activity of an apolipoprotein E mutant, APO E5, to LDL receptors on human fibroblasts.
Topics: Apolipoproteins E; Arteriosclerosis; Dimyristoylphosphatidylcholine; Fibroblasts; Humans; Hyperlipidemias; Isoelectric Focusing; Mutation; Receptors, LDL | 1990 |